Dhingra Kapil

Replimune Group, Inc. · Director

Dhingra Kapil is listed in public filings as director. This Dhingra Kapil insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Replimune Group, Inc. (REPL), LAVA Therapeutics N.V. (LVTX), and CARGO Therapeutics, Inc. Common Stock (CRGX). Investors use Dhingra Kapil's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Replimune Group, Inc.REPL$339k44.5k sharesGrant / ExerciseApr 1, 2026$338.6K44.5k shares$7.61--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Replimune Group, Inc.REPL$03.2k sharesSellDec 9, 2025$33.0K3.2k shares$10.40--
Replimune Group, Inc.REPL$03.2k sharesGrant / ExerciseDec 9, 2025$5.5K3.2k shares$1.75--
LAVA Therapeutics N.V.LVTX$030k sharesOtherNov 13, 2025$31.2K30k shares$1.04--
LAVA Therapeutics N.V.LVTX$033.4k sharesOtherNov 13, 2025$31.1K33.4k shares$0.93--
CARGO Therapeutics, Inc. Common StockCRGX$025k sharesOtherAug 19, 2025$108.8K25k shares$4.35--
CARGO Therapeutics, Inc. Common StockCRGX$109k25k sharesGrant / ExerciseJun 18, 2025$108.8K25k shares$4.35--
Replimune Group, Inc.REPL$269k32k sharesGrant / ExerciseApr 1, 2025$268.8K32k shares$8.40--
LAVA Therapeutics N.V.LVTX$31k33.4k sharesGrant / ExerciseFeb 13, 2025$31.1K33.4k shares$0.93--